Keyword Analysis & Research: nivolumab nsclc

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nivolumab nsclc	0.38	0.1	6040	6	15
nivolumab	1.86	0.7	3195	34	9
nsclc	1.4	0.8	1702	18	5

Keyword	CPC	PCC	Volume	Score
nivolumab nsclc	0.65	0.2	3946	11
nivolumab nsclc approval	0.23	1	1979	47
nivolumab nsclc neoadjuvant	1.66	0.5	8950	17
nivolumab nsclc fda approval	1.57	0.9	614	90
nivolumab ipilimumab nsclc	1.83	0.2	1458	92
ipilimumab and nivolumab nsclc	1.45	0.2	7436	7
neoadjuvant nivolumab nsclc fda	0.02	0.6	9765	71
neoadjuvant nivolumab nsclc nejm	1.98	0.1	366	45
neoadjuvant nivolumab nsclc fda approval	1.01	1	5647	94
nivolumab fda approval nsclc	0.04	0.4	4132	63
fda approval nivolumab nsclc	0.19	0.6	4878	38

OPDIVO® (nivolumab) + | YERVOY® (ipilimumab) Combo
bing.com

https://www.bing.com/aclk?ld=e8n15oQYYzhsbpCgwZ_irjejVUCUyDPgYgXmy19DsYVmVc5sUG8A1rkT80vwapeTx2OIYkqLoLAv_V9DcG6b9SiNYge_ddra12a6x6mgJX__pbV3sgRMjo6Q0AAsrv0pKS52I2h5PThGbmxlvO3NPd7vp9MAQDAFHTxUpDRIWJtnNyaajK&u=aHR0cHMlM2ElMmYlMmZ3d3cub3BkaXZvaGNwLmNvbSUyZmVmZmljYWN5JTJmbnNjbGMlM2ZjaWQlM2RzZW1fMjI0NjEyMCUyNmdjbGlkJTNkY2FlNGJlMjQ2MjQ4MWMzZjZlOGNkODBkY2JiNTBmZDYlMjZnY2xzcmMlM2QzcC5kcyUyNg&rlid=cae4be2462481c3f6e8cd80dcbb50fd6

Financial Assistance · Caregiver Information · Online Tools & Resources · Product Information

DA: 59 PA: 36 MOZ Rank: 55